牧原赴港：估值落差下的全球化突围

Core Viewpoint - Muyuan Foods, listed on the Shenzhen Stock Exchange in 2014, has passed the Hong Kong Stock Exchange listing hearing and is set to achieve A+H listing, with a current A-share market value of 249.1 billion RMB and a projected P/E ratio of 13.7 times for 2025 [1] Group 1: Business Overview - Muyuan Foods operates primarily in two segments: pig breeding and sales, and meat processing [2] - The company has established a complete industry chain covering pig breeding, raising, feed production, and sales, making it the world's largest pig breeding enterprise since 2021, with a global market share increasing from 2.6% in 2021 to 5.6% in 2024 [2] Group 2: Competitive Landscape - In the broader global and Hong Kong meat industry, Muyuan's valuation prospects post-listing require careful assessment, especially compared to competitors like WH Group, which has a market cap of just over 100 billion HKD and a dynamic P/E ratio below 10 times [3][4] - WH Group's business model, which includes downstream processing and sales, provides more stable profit margins compared to Muyuan's upstream focus, which is heavily influenced by commodity price fluctuations [3][4] Group 3: Valuation Comparisons - In the Hong Kong market, comparable companies such as Decon Agricultural and COFCO Joycome have long been valued at single-digit P/E ratios, reflecting market caution towards highly cyclical and asset-heavy industries like pig farming [5][6] - Both Decon and COFCO Joycome's market performance indicates that the Hong Kong market generally assigns lower valuation premiums to cyclical farming enterprises compared to their A-share counterparts [6] Group 4: Challenges and Strategic Path - Muyuan's upcoming Hong Kong listing aims to broaden international financing channels and enhance brand influence, but it faces the challenge of valuation disparity in a more mature market [7] - To attract international investors and align its valuation with its global leadership position, Muyuan must demonstrate its global expansion capabilities and the replicability of its cost advantages in Southeast Asia [7][8] Group 5: Globalization Strategy - The listing is a crucial step in Muyuan's global strategy, transitioning from a domestic leader to a globally recognized protein producer, which could shift market valuation logic from focusing solely on pig cycles to assessing global growth potential [8][9] - The long-term performance of Muyuan in the Hong Kong market will be a test of its cost management and execution of its globalization strategy, with its stock price dependent on international investors' confidence in its narrative of becoming a world-class player [9]